Inlyta (axitinib) dosing, indications | 合法藥品大搜索

None

Hypertension and hypertensive crisis reported in clinical trials, typically within the first month of treatment; blood pressure increases may appear as early as 4 days after initiating; blood pressure should be well controlled before starting therapy; dosage modification or discontinuation of treatment may be required (see Dosage Modification)

Although rare, arterial thromboembolic events (including deaths) reported during clinical trials

Venous thromboembolic events (eg, DVT, PE, retinal vein occlusion, retinal vein thrombosis) reported, including deaths

Hemorrhagic events (eg, cerebral hemorrhage, hematuria, hemoptysis, GI bleeding, melena) may occur

Rare occurrences of GI perforation and fistula formation reported

May cause thyroid dysfunction; monitor thyroid function before initiating and periodically throughout therapy

Stop treatment 24 hr before scheduled surgery

May cause pr...